Pluvicto, a prostate cancer drug, has gained expanded approval that triples the number of patients with metastatic disease ...

HealthDay News — Some commonly prescribed photosensitizing drugs increase skin cancer risk, according to a study published online March 18 in Photodermatology, Photoimmunology & Photomedicine.

Ms Brown's daughter, Megan Johnson, 29, said a drug treatment called Phesgo had changed her mum's life and allowed her to ...

The U.S Food & Drug Administration has granted approval for a targeted therapy called CABOMETYX ® to treat pancreatic ...

The European Commission on Friday approved AstraZeneca Plc (NASDAQ:AZN) and Daiichi Sankyo's (OTC:DSKNY) Enhertu (trastuzumab ...

Pluvicto can now be used before chemotherapy to treat a kind of metastatic prostate cancer, tripling the number of patients ...

Research from Weill Cornell Medicine has identified a molecular pathway linking omega-6 linoleic acid—a common dietary fat in ...

Most women with breast cancer who paused endocrine therapy to get pregnant did not restart treatment after having a child, ...

In a society increasingly reluctant to accept aging, scientific therapies aimed at combating it have found a growing market ...

Researchers sought to determine whether contemporary hormonal contraception methods are associated with risk of developing VTE.

Seth Wander, MD, PhD, discusses the tolerability of selective estrogen receptor degraders and next-generation anti-estrogen ...

A new review was published in , Volume 16, on March 13, 2025, titled "Signaling pathway dysregulation in breast cancer." ...